Barclays
DRNA

Barclays’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-42,226
Closed -$852K 3995
2021
Q3
$852K Sell
42,226
-19,684
-32% -$397K ﹤0.01% 2330
2021
Q2
$2.31M Sell
61,910
-65,707
-51% -$2.45M ﹤0.01% 1634
2021
Q1
$3.26M Buy
127,617
+101,362
+386% +$2.59M ﹤0.01% 1503
2020
Q4
$579K Sell
26,255
-7,665
-23% -$169K ﹤0.01% 2261
2020
Q3
$610K Sell
33,920
-5,031
-13% -$90.5K ﹤0.01% 2206
2020
Q2
$990K Buy
38,951
+18,698
+92% +$475K ﹤0.01% 1933
2020
Q1
$372K Sell
20,253
-69,742
-77% -$1.28M ﹤0.01% 2260
2019
Q4
$1.98M Buy
89,995
+59,544
+196% +$1.31M ﹤0.01% 1887
2019
Q3
$436K Sell
30,451
-26,666
-47% -$382K ﹤0.01% 2687
2019
Q2
$900K Buy
57,117
+11,845
+26% +$187K ﹤0.01% 2403
2019
Q1
$664K Sell
45,272
-1,440
-3% -$21.1K ﹤0.01% 2449
2018
Q4
$499K Buy
46,712
+29,615
+173% +$316K ﹤0.01% 2267
2018
Q3
$261K Buy
17,097
+13,760
+412% +$210K ﹤0.01% 2938
2018
Q2
$41K Sell
3,337
-38,253
-92% -$470K ﹤0.01% 3356
2018
Q1
$398K Buy
41,590
+20,112
+94% +$192K ﹤0.01% 2436
2017
Q4
$194K Buy
21,478
+21,400
+27,436% +$193K ﹤0.01% 2671
2017
Q3
$0 Hold
78
﹤0.01% 4201
2017
Q2
$0 Hold
78
﹤0.01% 4177
2017
Q1
$0 Sell
78
-3,401
-98% ﹤0.01% 4219
2016
Q4
$10K Buy
+3,479
New +$10K ﹤0.01% 3273
2016
Q3
Sell
-1,842
Closed -$6K 4128
2016
Q2
$6K Sell
1,842
-4,626
-72% -$15.1K ﹤0.01% 3109
2016
Q1
$32K Sell
6,468
-220
-3% -$1.09K ﹤0.01% 2670
2015
Q4
$73K Sell
6,688
-1,241
-16% -$13.5K ﹤0.01% 2392
2015
Q3
$64K Sell
7,929
-1,564
-16% -$12.6K ﹤0.01% 2513
2015
Q2
$123K Buy
9,493
+9,382
+8,452% +$122K ﹤0.01% 2279
2015
Q1
$3K Sell
111
-92
-45% -$2.49K ﹤0.01% 3847
2014
Q4
$3K Buy
203
+86
+74% +$1.27K ﹤0.01% 3999
2014
Q3
$1K Buy
117
+58
+98% +$496 ﹤0.01% 4254
2014
Q2
$1K Sell
59
-37
-39% -$627 ﹤0.01% 4244
2014
Q1
$3K Buy
+96
New +$3K ﹤0.01% 4114